Cargando…
Inter-Platform comparability of microarrays in acute lymphoblastic leukemia
BACKGROUND: Acute lymphoblastic leukemia (ALL) is the most common pediatric malignancy and has been the poster-child for improved therapeutics in cancer, with life time disease-free survival (LTDFS) rates improving from <10% in 1970 to >80% today. There are numerous known genetic prognostic va...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2004
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC522810/ https://www.ncbi.nlm.nih.gov/pubmed/15387886 http://dx.doi.org/10.1186/1471-2164-5-71 |